Verisk Vows to Fight Court Order Forcing $2.35B AccuLynx Deal
VRSK sits 16% above its 52-week low of $155.94.
Summary
Verisk publicly pushed back against a Delaware court ruling that orders it to complete the $2.35 billion acquisition of AccuLynx, a deal it had walked away from in December. The company said it 'strongly disagrees' and is evaluating an appeal, signaling a protracted legal battle. This follows the initial Reuters report of the ruling on August 8, but adds Verisk's combative stance, which raises uncertainty around the deal's outcome and potential damages. The dispute stems from Verisk's termination of the merger after the FTC's review extended beyond the deadline, with the court finding Verisk did not use commercially reasonable efforts to secure approval. With Verisk's market cap near $23.6 billion, the $2.35 billion deal is material, and a forced completion or damages could pressure its balance sheet, already strained by aggressive buybacks and debt. The next step is whether Verisk files an appeal, which could prolong the overhang.
At the time of this announcement, VRSK was trading at $181.15 on NASDAQ in the Technology sector, with a market capitalization of approximately $23.6B. The 52-week trading range was $155.94 to $276.19. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.